Science Explorer Interactive view Map
Company · Barcelona · Spain

Novartis (Spain)

novartis.esROR OpenAlex
World rank, all time
#30,549
of 42,892
Rank in Spain
#710
of 927
Research works
147
▼ 37% vs 2013–17
Citations
3.4k
23.3 per fractional work
Top-10% rate
12.5%
record average 16.5%
Open access
43%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.42× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.51× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 6.93× its world share, 1 worksImmunology and Micro…Neuroscience: 0.34× its world share, 0 worksNeuroscienceChemistry: 0.19× its world share, 0 worksChemistryComputer Science: 0.03× its world share, 0 worksComputer ScienceEngineering: 0.02× its world share, 0 worksEngineeringEnvironmental Science: 0.38× its world share, 0 worksEnvironmental ScienceMathematics: 2.54× its world share, 1 worksMathematicsDentistry: 0.43× its world share, 0 worksDentistryHealth Professions: 1.02× its world share, 0 worksHealth ProfessionsMedicine: 3.37× its world share, 12 worksMedicineBusiness, Management and Accounting: 0.20× its world share, 0 worksBusiness, Management…Decision Sciences: 0.31× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 5.44× its world share, 2 worksEconomics, Econometr…Psychology: 0.35× its world share, 0 worksPsychologySocial Sciences: 0.06× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.9×. Every wedge is a field page.

Which keywords describe research at Novartis (Spain)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Cardiovascular Disease, Inflammation, Quality of Life, Global Burden, Diagnosis, Treatment and Cardiovascular Risk.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology20▲ 3.4×48 topics
  2. Inflammation15▲ 4.4×27 topics
  3. Quality of Life12▲ 6.2×18 topics
  4. Cardiovascular Disease12▲ 7.4×16 topics
  5. Treatment10▲ 5.5×18 topics
  6. Diagnosis10▲ 6.5×16 topics
  7. Global Burden9▲ 12×8 topics
  8. Oxidative Stress8▲ 2.8×18 topics
  9. Cardiovascular Risk7▲ 14×9 topics
  10. Clinical Guidelines7▲ 16×5 topics
  11. Hypertension7▲ 13×7 topics
  12. Genetics6▲ 5.8×11 topics
  13. Management6▲ 5.5×13 topics
  14. Risk Factors6▲ 4.1×10 topics
  15. Diabetic Retinopathy6▲ 51×2 topics
  16. Macular Degeneration6▲ 34×3 topics
  17. Diagnostic Criteria6▲ 19×7 topics
  18. Cardiovascular Events6▲ 23×3 topics
  19. Asthma5▲ 28×2 topics
  20. Cost-effectiveness Analysis5▲ 45×1 topic
  21. Diabetes Mellitus5▲ 16×2 topics
  22. Health Utility Measures5▲ 45×1 topic
  23. Blood Pressure5▲ 50×2 topics
  24. Immunology5▲ 28×2 topics
  25. Antihypertensive Drugs5▲ 60×1 topic
  26. Renal Denervation5▲ 60×1 topic
  27. Clinical Trials5▲ 5.1×12 topics
  28. Diabetes5▲ 6.1×10 topics
  29. Allergic Diseases4▲ 38×1 topic
  30. Ankylosing Spondylitis4▲ 134×1 topic
  31. Eosinophils4▲ 38×1 topic
  32. Spondyloarthritis4▲ 134×1 topic
  33. Autoantibodies4▲ 12×6 topics
  34. Glycemic Control4▲ 20×4 topics
  35. Vascular Endothelial Growth Factor4▲ 27×2 topics
  36. Intravitreal Injection4▲ 39×2 topics
  37. TGF-ß4▲ 15×3 topics
  38. Cognitive Impairment4▲ 11×5 topics
  39. Choroidal Thickness4▲ 50×1 topic
  40. Medication Adherence4▲ 44×2 topics

Which research topics does Novartis (Spain) publish most on?

By volume in 2022–2025: Health Systems, Economic Evaluations, Quality of Life, Ophthalmology and Visual Impairment Studies, Psoriasis: Treatment and Pathogenesis and Spondyloarthritis Studies and Treatments.

Health Systems, Economic…2Health Systems, Economic Evaluations, Quality of Life: 2 fractional worksOphthalmology and Visual Impairment Studies: 1 fractional worksPsoriasis: Treatment and Pathogenesis: 1 fractional worksSpondyloarthritis Studies and Treatments: 1 fractional worksRetinal Diseases and Treatments: 1 fractional worksRenal Diseases and Glomerulopathies: 1 fractional worksRheumatoid Arthritis Res…1Rheumatoid Arthritis Research and Therapies: 1 fractional worksHeart Failure Treatment and Management: 0 fractional worksPharmaceutical studies and practices: 0 fractional worksPharmaceutical Economics and Policy: 0 fractional works
Economics and EconometricsEpidemiologyImmunologyRheumatology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 2 works
  2. 2 Ophthalmology and Visual Impairment Studies Epidemiology 1 works
  3. 3 Psoriasis: Treatment and Pathogenesis Immunology 1 works
  4. 4 Spondyloarthritis Studies and Treatments Rheumatology 1 works
  5. 5 Retinal Diseases and Treatments Ophthalmology 1 works
  6. 6 Renal Diseases and Glomerulopathies Nephrology 1 works
  7. 7 Rheumatoid Arthritis Research and Therapies Rheumatology 1 works
  8. 8 Heart Failure Treatment and Management Cardiology and Cardiovascular Medicine 0 works
  9. 9 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 0 works
  10. 10 Pharmaceutical Economics and Policy Economics and Econometrics 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available43.3%not open56.7%

World: 28% of research is openly available.

with international co-authors26.2%domestic only73.8%

World: 19% is written across borders.

How has Novartis (Spain)'s research output changed?

Output in 2018–2022 was 37% lower than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Barcelona

All research institutions in Barcelona

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.